Platelet Count to Prothrombin Time: A Noninvasive Predictor of Esophageal Varices in Patients With Chronic Liver Disease

• Published in: Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e59627-e59627
• Main Authors: Rizvi, Syed Rohail Ahmed, Wallam, Muhammad Danish Ashraf, Siddiqui, Arif Rasheed, Haqqi, Syed Afzal Ul Haq, Farrukh, Zea Ul Islam, Niaz, Saad Khalid, Farooq, Muhammad Umar, Kakar, Fahad, Hashmi, Atif A
• Format: Article
• Language: English
• Subjects: Ascites; Body mass index; Endoscopy; Esophagus; Etiology; Fatalities; Females; Gastroenterology; Hepatitis B; Hepatitis C; Hepatitis delta virus; Hypertension; Internal Medicine; Liver cirrhosis; Liver diseases; Males; Patients; Tomography; Ultrasonic imaging; Veins & arteries
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.59627

Introduction Esophageal variceal bleeding is a potentially deadly consequence of portal hypertension in patients with cirrhosis. Although upper gastrointestinal endoscopy is still the preferred method for identifying esophageal varices (EV), the present study measured the platelet count to prothrombin time (PLT/PT) ratio for the assessment of portal hypertension and subsequent diagnosis of EVs in patients with chronic liver disease (CLD). Methods This was an observational comparative study conducted in the outpatient department of Patel Hospital, Karachi, Pakistan, using a non-probability consecutive sampling technique. Ethical approval was obtained from the Patel Hospital ethical review committee (PH/IRB/2022/028). An independent sample t-test was used for parametric data, whereas the Mann-Whitney U test was used for non-parametric data. The chi-square test was used to compare the categorical data of patients with and without EV. Receiver operating characteristic (ROC) analysis was performed to evaluate the cutoff values for the PLT/PT ratio, sensitivity, specificity, and area under the curve (AUC). Results The study involved 105 patients with and without EV. Among them, 38 (63.3%) males and 22 (36.7%) females had EV, whereas 30 (66.7%) males and 15 (33.3%) females did not. The platelet (PLT) count was also significantly lower in patients with EV (87.6 ± 59.8) than in those without (176.6 ± 87.7) (p < 0.001). The PLT/PT ratio was significantly lower in patients with EV (median: 5.04, IQR: 3.12-9.21) compared to those without (median: 14.57, IQR: 8.08-20.58) (p < 0.001). The sensitivity and specificity of the PLT/PT ratio for identifying EVs were 97.80% and 83.30%, respectively. Conclusion We found a significantly lower PLT/PT ratio in cases with EV than those without EV. After defining an optimal cutoff, PLT/PT had a high sensitivity in identifying cases with EVs in CLD. Therefore, we conclude that in patients with CLD, the PLT/PT ratio is a noninvasive predictor for the presence of EV.